Serum infliximab levels and clinical response in hidradenitis suppurativa

Serum infliximab levels and clinical response in hidradenitis suppurativa

Abstract Background Infliximab (IFX) is a chimeric immunoglobulin G‐1κ monoclonal antibody that neutralises the biologic activity of tumour necrosis factor‐α, and has shown efficacy (off‐label) for the treatment of severe hidradenitis suppurativa (HS). The relationship between clinical response and...

Full description

Saved in:
Bibliographic Details
Main Authors: Erwin Benassaia (Author), Jean‐David Bouaziz (Author), Marie Jachiet (Author), Florence Cordoliani (Author), Anne Saussine (Author), Clemence Lepelletier (Author), Lauriane Goldwirt (Author), Charles Cassius (Author), Adèle deMasson (Author), Martine Bagot (Author), Hervé Bachelez (Author), Florence Assan (Author)
Format: Book
Published: Wiley, 2023-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items